InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Gassert Chad, SVP, Développement Corporatif et Stratégie. Director active across 1 companies, notably ANI Pharmaceuticals INC. In total, 3 reports have been published. Total volume traded: €122k. The latest transaction was filed on 18 March 2022 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations3 total
€122,2975,000 shares@ €24.45940.0069% mcap100.0% of flow
Common Stock
SEC:0001415889-22-003267:0·
Ideal exit: 13 Dec 2022 (T+270)
383,226 shares
Common Stock
SEC:0001415889-21-005442·
383,226 shares
Common Stock
SEC:0001415889-21-005442:0·
3 of 3 declarations
About Gassert Chad
Chad Gassert is the SVP of Corp. Dev. & Strategy at ANI PHARMACEUTICALS INC. He is responsible for developing and implementing the company's growth strategies. His role is essential in identifying new market opportunities and strengthening the company's competitive position. He works closely with management to align strategic initiatives with the company's overall goals.
